# Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects

> **NCT01405599** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 32 (actual)

## Conditions studied

- Digestive System Disorders

## Interventions

- **DRUG:** Ulimorelin

## Key facts

- **NCT ID:** NCT01405599
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405599, "Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01405599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*